Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Merit Medical (NASDAQ: MMSI) will release first quarter 2026 financial results after market close on Thursday, April 30, 2026. The company will hold an investor conference call the same day at 4:30 p.m. ET with a live webcast and slide deck available online.
Investors may pre-register for dial-in details; registration and webcast links will be posted at www.merit.com. Merit develops and distributes proprietary medical devices and employs about 7,600 people with over 800 sales and clinical support staff worldwide.
Details
News Market Reaction – MMSI
On Apr 6, the first trading day after this news, MMSI closed 0.16% above the previous close.
Data tracked by StockTitan Argus for the Apr 6 session.
Key Figures
- Earnings release date
- April 30, 2026
- Q1 2026 results release after market close
- Quarter end date
- March 31, 2026
- Quarter for upcoming earnings report
- Conference call time
- 4:30 p.m. Eastern
- Investor call on April 30, 2026
- Call regional times
- 3:30 p.m. Central / 2:30 p.m. Mountain / 1:30 p.m. Pacific
- Investor conference call time zones
- Founded
- 1987
- Year Merit Medical was founded
- Sales & clinical team
- 800+ individuals
- Domestic and international sales and clinical support force
- Employees
- ≈7,600 people
- Worldwide employee count
Historical Context
-
Acquisition of View Point Medical for about $140M to expand oncology portfolio.
-
Distribution agreement with Medtronic for FDA-cleared ViaVerte BVNA system.
-
US launch of Resilience TTS Esophageal Stent for fistulas and malignant strictures.
-
Reported FY2025 growth and issued higher FY2026 revenue and EPS guidance.
-
New board chair and strong preliminary Q4 2025 revenue growth guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
cardiology medical
radiology medical
oncology medical
endoscopy medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).
To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.
A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.
ABOUT MERIT
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.
| Contacts: | |
| PR/Media Inquiries: Sarah Comstock Merit Medical | Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare |
| +1-801-432-2864 | +1-443-213-0509 |
| sarah.comstock@merit.com | mike.piccinino@icrhealthcare.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.